Advertisement

Ads Placeholder
Loading...

ScripsAmerica, Inc.

SCRCQPNK
Healthcare
Medical - Pharmaceuticals
$0.00
$0.00(0.00%)
U.S. Market opens in 50h 43m

ScripsAmerica, Inc. Fundamental Analysis

ScripsAmerica, Inc. (SCRCQ) shows weak financial fundamentals with a PE ratio of -0.00, profit margin of -15.33%, and ROE of 1.63%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position3564.96%
PEG Ratio-0.00

Areas of Concern

ROE1.63%
Operating Margin-12.34%
Current Ratio0.67
We analyze SCRCQ's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 44.4/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
44.4/100

We analyze SCRCQ's fundamental strength across five key dimensions:

Efficiency Score

Weak

SCRCQ struggles to generate sufficient returns from assets.

ROA > 10%
-83.82%

Valuation Score

Excellent

SCRCQ trades at attractive valuation levels.

PE < 25
-0.00
PEG Ratio < 2
-0.00

Growth Score

Weak

SCRCQ faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

SCRCQ shows balanced financial health with some risks.

Debt/Equity < 1
-0.37
Current Ratio > 1
0.67

Profitability Score

Moderate

SCRCQ maintains healthy but balanced margins.

ROE > 15%
162.57%
Net Margin ≥ 15%
-15.33%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is SCRCQ Expensive or Cheap?

P/E Ratio

SCRCQ trades at -0.00 times earnings. This suggests potential undervaluation.

-0.00

PEG Ratio

When adjusting for growth, SCRCQ's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values ScripsAmerica, Inc. at -0.00 times its book value. This may indicate undervaluation.

-0.00

EV/EBITDA

Enterprise value stands at 0.19 times EBITDA. This is generally considered low.

0.19

How Well Does SCRCQ Make Money?

Net Profit Margin

For every $100 in sales, ScripsAmerica, Inc. keeps $-15.33 as profit after all expenses.

-15.33%

Operating Margin

Core operations generate -12.34 in profit for every $100 in revenue, before interest and taxes.

-12.34%

ROE

Management delivers $1.63 in profit for every $100 of shareholder equity.

1.63%

ROA

ScripsAmerica, Inc. generates $-83.82 in profit for every $100 in assets, demonstrating efficient asset deployment.

-83.82%

Following the Money - Real Cash Generation

Operating Cash Flow

ScripsAmerica, Inc. generates limited operating cash flow of $772.47K, signaling weaker underlying cash strength.

$772.47K

Free Cash Flow

ScripsAmerica, Inc. generates weak or negative free cash flow of $649.40K, restricting financial flexibility.

$649.40K

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

SCRCQ converts 41.57% of its market value into free cash.

41.57%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.00

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.00

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.37

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.67

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

1.63

vs 25 benchmark

ROA

Return on assets percentage

-0.84

vs 25 benchmark

ROCE

Return on capital employed

3.41

vs 25 benchmark

How SCRCQ Stacks Against Its Sector Peers

MetricSCRCQ ValueSector AveragePerformance
P/E Ratio-0.0028.45 Better (Cheaper)
ROE162.57%763.00% Weak
Net Margin-15.33%-45265.00% (disorted) Weak
Debt/Equity-0.370.34 Strong (Low Leverage)
Current Ratio0.672795.60 Weak Liquidity
ROA-83.82%-16588.00% (disorted) Weak

SCRCQ outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews ScripsAmerica, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ